publication venue for
- Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease. 211:115501-115501. 2023
- Corrigendum to “Obesity II: Establishing causal links between chemical exposures and obesity” [Biochem. Pharmacol. 199 (2022) 115015]. 202:115144-115144. 2022
- Obesity II: Establishing causal links between chemical exposures and obesity. 199:115015-115015. 2022
- Cell-specific drug targeting in the lung. 190:114577-114577. 2021
- Exploring the role of nerves in asthma; insights from the study of cough. 179:113901-113901. 2020
- Non-coding RNAs as antibiotic targets. 133:29-42. 2017
- The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway. 101:100-111. 2016
- Hsp90 inhibitors, GA and 17AAG, lead to ER stress-induced apoptosis in rat histiocytoma. 78:142-152. 2009
- Metabolism of nilutamide in rat lung. 71:377-385. 2006
- Influence of the proto-oncogene c-fos on cisplatin sensitivity. 59:337-345. 2000
- Dual effects of SK&F 96365 in human leukemic HL-60 cells. 51:605-612. 1996
- Effect of alkyl-N-purine DNA glycosylase overexpression on cellular resistance to bifunctional alkylating agents. 50:39-44. 1995
- Potentiation of chlorambucil toxicity in B-CLL lymphocytes using the DNA synthesis inhibitors aphidicolin and 1-β-d-arabinofuranosylcytosine. 50:131-135. 1995
- Pharmacological inhibition of forskolin-stimulated adenylate cyclase activity in rat brain by melatonin, its analogs, and diazepam. 40:2701-2705. 1990
- Determination of soluble CAMP-dependent protein kinase activity in guinea-pig tracheal smooth muscle. 39:1365-1374. 1990
- Development of a specific assay for cardiac glycoside-like compounds based on cross-resistance of human cell mutants. 38:2159-2168. 1989
- Melatonin enhancement of [3H]-γ-aminobutyric acid and [3H]muscimol binding in rat brain. 37:1271-1274. 1988
- Human cell mutants affected in the interaction of the 12β-OH group of cardiac glycosides with the digitalis receptor. 36:3829-3833. 1987
- Lipid peroxidation stimulated by iron nitrilotriacetate in rat liver. 35:2381-2387. 1986
- Adriamycin cardiomyopathy: Implications of cellular changes in a canine model with mild impairment of left ventricular function. 34:4033-4041. 1985
- Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450. 33:3899-3902. 1984
- Ferric nitrilotriacetate: A potent stimulant of lipid peroxidation in mice. 32:3879-3882. 1983
- Factors affecting solubilized dopamine-sensitive adenylate cyclase. 32:1237-1241. 1983
- Cyclic AMP response to norepinephrine in the limbic forebrain of male and female rats: effect of desipramine. 30:3126-3128. 1981
- Mutants of HeLa cells resistant to ouabain and cassaine: Genetic evidence for the common site of action of cardiac glycosides and erythrophleum alkaloids. 30:3039-3044. 1981
- Modification of in vivo methotrexate antitumor effect in L1210 leukemia by induced impairment of purine salvage. 30:869-874. 1981
- Studies with a 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP)-resistant L1210 leukemia cell line without cross-resistance to methotrexate. 29:2241-2245. 1980
- Effect of D-lysergic acid diethylamide on striatal choline acetyltransferase activity in the rat. 28:2207-2209. 1979
- Modification of skeletal muscle sarcotubular Ca2+ -stimulated adenosine triphosphatase activity by various agents. 25:2271-2274. 1976
- Effects of reserpine and serotonin on adenine nucleotide metabolism and glucose oxidation of washed rabbit platelets. 26:1667-1670. 1977